17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
Clinical trial NCT00100997 · COMPLETED
Trial details
- NCT number
- NCT00100997
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.